← back to search

Michael T. Spiotto

The University of Texas MD Anderson Cancer Center · US
Area of research
Otorhinolaryngology · Surgery
Research interest
Research interests include Head and Neck Cancer Studies, Head and Neck Surgical Oncology, Immunotherapy and Immune Responses, and Advanced Radiotherapy Techniques.
h-index
32
citations
5,079
works
226
NIH funding
primary concept
email

Recent publications

Hamidi S, Vodopivec DM, Busaidy NL, Gule-Monroe M, Akhave NS, Banuchi VE, Ferraroto R, Fournier I, Gunn GB, Iyer PC, Lee A, Maniakas A, Marczyk VR, Ning MS, Sousa LG, Spiotto MT , Waguespack SG, Wang JR, Zafereo ME, Cabanillas ME, Dadu R . Real-World Experience with Lenvatinib plus Pembrolizumab in
2026cited by 0position: selected
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial
The Lancet 2025cited by 20position: middledoi
Exploring TROP2 expression in oropharyngeal squamous cell carcinoma: Association with prognosis and tumor immune microenvironment composition.
2025cited by 0position: selecteddoi
Siqueira, JM, Heguedusch, D, Cunha, MT, Guimares de Sousa, L, Marques-Piubelli, ML, Carvalho, GL, Hoff, CO, Bonini, F, Mitani, Y, Spiotto, MT , Goepfert, RP, Nunes, FD, De Matos, LL, Kowalski, LP, McGrail, DJ, El-Naggar, AK, Ferrarotto, R . Exploring TROP2 expression in oropharyngeal squamous cell c
2025cited by 0position: selected
Siqueira, JM, Mitani, Y, Marques-Piubelli, ML, Hoff, CO, Bonini, F, De Sousa, LG, Mitani, M, Carvalho, GL, Nunes, FD, De Matos, LL, Lin, S, Spiotto, MT , Hanna, EY, McGrail, DJ, El-Naggar, AK, Ferrarotto, R . TROP2 Expression in Salivary Gland Adenoid Cystic Carcinoma (ACC) According to Histologic S
2025cited by 0position: selected
Siqueira JM, Heguedusch D, Cunha MT, de Sousa LG, Marques-Piubelli ML, Carvalho GL, Hoff CO, Bonini F, Mitani Y, Spiotto MT , Goepfert R, Nunes FD, Matos LL, Kowalski LP, McGrail DJ, El-Naggar AK, Ferrarotto R . Exploring TROP2 expression in oropharyngeal squamous cell carcinoma: Association with pr
2025cited by 0position: selected
Goodman CD, DeMonte F, Nguyen TP, Garden AS, Wang CH, Wang XA, Diao K, Lee A, Reddy J, Moreno A, Spiotto M , Fuller CD, Rosenthal D, Ferrarotto R, Raza SM, Su SY, Warner A, Hanna E, Phan J . A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory ne
2025cited by 0position: selected
Hamidi S, Dadu R, Zafereo ME, Ferrarotto R, Wang JR, Maniakas A, Gunn GB, Lee A, Spiotto MT , Iyer PC, Sousa LG, Akhave NS, Ahmed S, Learned KO, Lu C, Lai SY, Williams M, Hosseini SM, Busaidy NL, Cabanillas ME . Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidiscip
2024cited by 0position: selected
Siqueira JM, Mitani Y, Hoff CO, Bonini F, Guimaraes de Sousa L, Marques-Piubelli ML, Purushothaman A, Mitani M, Dai H, Lin SY, Spiotto MT , Hanna EY, McGrail DJ, El-Naggar AK, Ferrarotto R . Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Progn
2024cited by 0position: selected
Maroongroge S, Mohamed AS, Nguyen C, Guma De la Vega J, Frank SJ, Garden AS, Gunn BG, Lee A, Mayo L, Moreno A, Morrison WH, Phan J, Spiotto MT , Court LE, Fuller CD, Rosenthal DI, Netherton TJ . Clinical acceptability of automatically generated lymph node levels and structures of deglutition and mas
2024cited by 0position: selected
A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors.
Journal of Clinical Oncology 2023cited by 38position: middledoi
Contrera KJ, Phan J, Waguespack SG, Aldehaim M, Wang X, Lim TY, Roberts DB, Fuller CD, Spiotto MT , Raza SM, DeMonte F, Hanna EY, Su SY . Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head Neck 45(10):2525-2532, 2023. e-Pub 2023. PM
2023cited by 0position: selected
Ganesh A, Korpics M, Pasquinelli M, Feldman L, Spiotto MT , Koshy M . Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC. Clinical Lung Cancer 24(1):60-71, 2023. e-Pub 2022. PMID: 36289032.
2023cited by 0position: selected
Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework
Nature Biomedical Engineering 2022cited by 104position: middledoi
Korpics MC, Turchan WT, Koshy M, Spiotto MT . Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis. Head Neck 44(7):1528-1544, 2022. e-Pub 2022. PMID: 35393753.
2022cited by 0position: selected
Ganesh A, Katipally R, Pasquinelli M, Feldman L, Spiotto MT , Koshy M . Increased Disparities in Patients Diagnosed with Metastatic Lung Cancer Following Lung CT Screening in the United States. Clinical Lung Cancer 23(2):151-158, 2022. e-Pub 2022. PMID: 34924304.
2022cited by 0position: selected
Ni K, Xu Z, Culbert A, Luo T, Guo N, Yang K, Pearson E, Preusser B, Wu T, La Riviere P, Weichselbaum RR, Spiotto MT , Lin W . Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework. Nature Biomedical Engineering 6(2):144-156, 2
2022cited by 0position: selected
Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy–Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression
ACS Nano 2021cited by 45position: middledoi
Impact of anatomic site of distant metastasis on survival in salivary gland cancers
Head & Neck 2021cited by 10position: lastdoi
Guo N, Ni K, Luo T, Lan G, Arina A, Xu Z, Mao J, Weichselbaum RR, Spiotto MT , Lin W . Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression. ACS Nano 15(11):17515-17527, 2021. e-Pub 2021. PMID: 3470
2021cited by 0position: selected
Diao K, Nguyen TP, Moreno AC, Reddy JP, Garden AS, Wang CH, Tung S, Wang C, Wang XA, Rosenthal DI, Fuller CD, Gunn GB, Frank SJ, Morrison WH, Shah SJ, Lee A, Spiotto MT , Su SY, Ferrarotto R, Phan J . Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is
2021cited by 0position: selected
Turchan, WT, Korpics, MC, Rooney, MK, Koshy, M, Spiotto, MT . Impact of anatomic site of distant metastasis on survival in salivary gland cancers. Head and Neck 43(9):2589-2601, 2021. e-Pub 2021. PMID: 33961718.
2021cited by 0position: selected
Rooney, MK, Korpics, MC, Turchan, WT, Callahan, N, Koshy, M, Spiotto, MT . Patterns of Care and Survival Outcomes for Odontogenic Cancers. Laryngoscope 131(5):E1496-E1502, 2021. e-Pub 2021. PMID: 33135786.
2021cited by 0position: selected
Turchan, WT, Gutiontov, SI, Spiotto, MT , Liauw, SL . Prostate Cancer Radiotherapy. JNCI Cancer Spectrum 4(6), 2021. e-Pub 2021. PMID: 33409456.
2021cited by 0position: selected
Spiotto MT , McGovern SL, Gunn GB, Grosshans D, McAleer MF, Frank SJ, Paulino AC . Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers. International Journal of Particle Therapy 8(1):155-167, 2021. e-Pub 2021. PMID: 34285943.
2021cited by 0position: selected
Machine Learning–Guided Adjuvant Treatment of Head and Neck Cancer
JAMA Network Open 2020cited by 146position: middledoi
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer
International Journal of Radiation Oncology*Biology*Physics 2020cited by 48position: lastdoi
Machine learning guided adjuvant treatment of head and neck cancer.
Journal of Clinical Oncology 2020cited by 17position: middledoi
Cooperation of genes in HPV16 <i>E6/E7</i>-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens
Carcinogenesis 2020cited by 12position: middledoi
Howard FM, Kochanny S, Koshy M, Spiotto MT , Pearson AT . Machine Learning-Guided Adjuvant Treatment of Head and Neck Cancer. JAMA Netw Open 3(11):e2025881, 2020. e-Pub 2020. PMID: 33211108.
2020cited by 0position: selected

Grants

No grants ingested yet.

Frequent collaborators

Ralph R. Weichselbaum · University of Chicago Medical Center16 papers (2013–2023)Matthew Koshy · University of Illinois Chicago11 papers (2016–2023)Barry L. Wenig · University of Illinois Chicago4 papers (2013–2018)David J. Sher · State Key Laboratory of Biotherapy4 papers (2017–2019)Wenbin Lin · Guangdong University of Technology4 papers (2018–2023)Lawrence Feldman · University of Illinois Chicago4 papers (2013–2023)Chad G. Rusthoven · University of Colorado Cancer Center3 papers (2017–2019)Kaiyuan Ni · Massachusetts Institute of Technology3 papers (2018–2022)Alexander T. Pearson · RWTH Aachen University3 papers (2020–2023)Daniel J. Haraf · University of Illinois Chicago3 papers (2013–2016)Nining Guo · Drug Discovery Laboratory (Norway)3 papers (2018–2022)Gina D. Jefferson · University of Illinois Chicago2 papers (2015–2017)Elizabeth A. Blair · Elgin Community College2 papers (2013–2016)Ezra E.W. Cohen · University of Michigan2 papers (2013–2016)Michael K. Rooney · University of Illinois Chicago2 papers (2019–2021)Frederick M. Howard · University of Chicago2 papers (2020–2020)Yang‐Xin Fu · Xiangyang Hospital of Traditional Chinese Medicine2 papers (2016–2016)Lucy Chen · Carleton University2 papers (2013–2013)Theodore Karrison · NRG Oncology2 papers (2016–2020)Gini F. Fleming · Sydney Local Health District2 papers (2020–2023)